SHP Wealth Management’s AngioDynamics ANGO Stock Holding History

SHP Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.32K	Hold	255	–	–	﹤0.01%	1255
2026 Q1	$2.9K	Hold	255	–	–	﹤0.01%	1200
2025 Q4	$3.27K	Buy	+255	New	+$3.15K	﹤0.01%	1053

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SHP Wealth Management's ANGO Position: Q2 2026 in Review

SHP Wealth Management held its AngioDynamics (ANGO) position steady in Q2 2026 at 255 shares worth $3.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

SHP Wealth Management first reported a position in ANGO in Q4 2025 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

SHP Wealth Management held 255 shares of AngioDynamics worth $3.32K as of Q2 2026.
SHP Wealth Management left its AngioDynamics share count unchanged in Q2 2026.
AngioDynamics made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1255 holding.
SHP Wealth Management first reported a position in AngioDynamics in Q4 2025 and has held it in 3 quarters since.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.